Sulpiride-induced	sulpiride-induced	O	O
tardive	tardive	O	B_disease
dystonia	dystonia	O	S_disease
.	.	O	O

Sulpiride	sulpiride	S_chemical	O
is	is	O	O
a	a	O	O
selective	selective	O	O
D2-receptor	d2-receptor	O	O
antagonist	antagonist	O	O
with	with	O	O
antipsychotic	antipsychotic	O	O
and	and	O	O
antidepressant	antidepressant	S_chemical	O
properties	properties	O	O
.	.	O	O

Although	although	O	O
initially	initially	O	O
thought	thought	O	O
to	to	O	O
be	be	O	O
free	free	O	O
of	of	O	O
extrapyramidal	extrapyramidal	O	S_disease
side	side	O	B_disease
effects	effects	O	I_disease
,	,	O	O
sulpiride-induced	sulpiride-induced	O	O
tardive	tardive	O	B_disease
dyskinesia	dyskinesia	O	S_disease
and	and	O	O
parkinsonism	parkinsonism	O	S_disease
have	have	O	O
been	been	O	O
reported	reported	O	O
occasionally	occasionally	O	O
.	.	O	O

We	we	O	O
studied	studied	O	O
a	a	O	O
37-year-old	37-year-old	O	O
man	man	O	O
who	who	O	O
developed	developed	O	O
persistent	persistent	O	O
segmental	segmental	O	O
dystonia	dystonia	O	S_disease
within	within	O	O
2	2	O	O
months	months	O	O
after	after	O	O
starting	starting	O	O
sulpiride	sulpiride	S_chemical	O
therapy	therapy	O	O
.	.	O	O

We	we	O	O
could	could	O	O
not	not	O	O
find	find	O	O
any	any	O	O
previous	previous	O	O
reports	reports	O	O
of	of	O	O
sulpiride-induced	sulpiride-induced	O	O
tardive	tardive	O	B_disease
dystonia	dystonia	O	S_disease
.	.	O	O

